Canonical: https://ownershiptrace.com/13f/companies/2424

# Who owns Definium Therapeutics, Inc. (DFT)? Elite investor 13F holders

4 tracked elite investors reported holding Definium Therapeutics, Inc as of 2026-06-30, including Duquesne Family Office, D.E. Shaw, Gotham Asset Management, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Duquesne Family Office](https://ownershiptrace.com/13f/investors/30) | Definium Therapeutics Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 16774000.00 USD | 356600.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1536411/0001536411-26-000006-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | Definium Therapeutics Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 14836887.00 USD | 315410.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | Definium Therapeutics Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 207540.00 USD | 4412.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | Definium Therapeutics Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12136.00 USD | 258.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)